Drug Shortage Report for ACCUTANE
| Report ID | 229983 |
| Drug Identification Number | 00582352 |
| Brand name | ACCUTANE ROCHE |
| Common or Proper name | Accutane |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ISOTRETINOIN |
| Strength(s) | 40MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 40MG x 30s |
| ATC code | D10BA |
| ATC description | ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-10-01 |
| Actual start date | 2024-10-01 |
| Estimated end date | 2025-05-31 |
| Actual end date | 2025-04-01 |
| Shortage status | Resolved |
| Updated date | 2025-04-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | HUEBWEG 18-20 BINNINGEN, SWITZERLAND 4102 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-08-02 | English | Compare |
| v2 | 2024-06-07 | French | Compare |
| v1 | 2024-06-07 | English | Compare |